Canadian CRO KGK signs pact with health screening provider Predictmedix
2024-02-15
并购
Preview
来源: FierceBiotech
KGK Science, which is based in London, Ontario, was acquired by Auxly Cannabis Group in 2018 in a cash and stock deal valued at $12.3 million.
KGK Science, a Canadian CRO focused on health and wellness, signed a partnership with Predictmedix AI, which provides health screening and remote patient care solutions.
The deal meshes Predictmedix’s health assessment technologies with KGK’s clinical research and regulatory experience with the goal of making “transformative changes in healthcare innovation,” the company said in a Feb. 12 press release. The two companies will work together on patient screening, health data collection accuracy and continuous monitoring.
Financial terms of the agreement weren't disclosed.
KGK, which is based in London, Ontario, was acquired by Auxly Cannabis Group in 2018 in a cash and stock deal valued at $12.3 million.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
-靶点
-药物
-来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。